ctrl K

Watchlist Price Alert

Phathom Pharmaceuticals I... (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

4.24

-0.07 (-1.62%)

At close: May 30, 2025, 3:59 PM

4.25

0.19%

After-hours: May 30, 2025, 05:31 PM EDT

Phathom Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	55.25M	682K	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	7.97M	167K	620K	521K	300K	8K	n/a
Gross Profit	47.28M	515K	-620K	-521K	-300K	-8K	n/a
Operating Income	-277.47M	-167.31M	-172.44M	-135.08M	-125.67M	-106.22M	-1.23M
Interest Income	15.16M	7.88M	2.13M	41K	1.09M	1.09M	n/a
Pretax Income	-334.33M	-201.59M	-197.72M	-143.88M	-129.07M	-255.13M	-1.29M
Net Income	-334.33M	-201.59M	-223.01M	-148.09M	-133.32M	-209.74M	-1.29M
Selling & General & Admin	290.66M	117.93M	101M	62.74M	27.52M	6.94M	1.21M
Research & Development	34.08M	49.9M	71.44M	72.34M	98.15M	99.27M	20K
Other Expenses	n/a	n/a	-110K	-2.06M	-8K	-49.56M	-50K
Operating Expenses	324.75M	167.83M	172.44M	135.08M	125.67M	106.22M	1.23M
Interest Expense	72.01M	41.97M	27.3M	6.79M	4.58M	4.18M	13K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	332.72M	167.99M	172.44M	135.08M	125.67M	106.22M	1.23M
Income Tax Expense	n/a	n/a	25.28M	4.21M	4.25M	-45.39M	13K
Shares Outstanding (Basic)	63.18M	51.29M	39.12M	37M	33.23M	24.73M	8.58M
Shares Outstanding (Diluted)	63.18M	51.29M	39.12M	37M	33.23M	24.73M	8.58M
EPS (Basic)	-5.29	-3.93	-5.7	-4	-4.01	-8.48	-0.15
EPS (Diluted)	-5.29	-3.93	-5.7	-4	-4.01	-8.48	-0.15
EBITDA	-261.52M	-159.05M	-171.82M	-134.56M	-124.19M	-250.95M	-50K
EBIT	-262.32M	-159.62M	-170.42M	-137.09M	-124.49M	-250.95M	-1.27M
Depreciation & Amortization	795K	575K	620K	521K	300K	8K	1.23M